Affinage

PPP2CB

Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform · UniProt P62714

Round 2 corrected
Length
309 aa
Mass
35.6 kDa
Annotated
2026-04-28
85 papers in source corpus 18 papers cited in narrative 18 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

PPP2CB encodes the β catalytic subunit of protein phosphatase 2A (PP2A), a serine/threonine phosphatase with substrate-specific roles distinct from its α isoform PPP2CA. PPP2CB dephosphorylates G9a/EHMT2 at Thr1045 during late mitosis to restore H3K9me2 and permit normal mitotic exit (PMID:37661576), dephosphorylates LC3B to suppress PINK1/Parkin-mediated mitophagy (PMID:41059761), and dephosphorylates TBK1 to dampen IFN-β antiviral signaling until PPP2CB is itself degraded by the REGγ-proteasome pathway (PMID:40736577). In T cells, PPP2CB negatively regulates PI3K/Akt signaling and Ca²⁺ flux to restrain activation (PMID:35068054), while in vascular smooth muscle cells it is transcriptionally upregulated by the YAP1/TEAD1 axis to inhibit AMPK and activate mTORC1-driven proliferation (PMID:41797917).

Mechanistic history

Synthesis pass · year-by-year structured walk · 11 steps
  1. 1993 High

    Chromosomal mapping of PPP2CB to 8p12 and identification of a chromosome 16 pseudogene established the gene's genomic identity and distinguished it from PPP2CA.

    Evidence Somatic cell hybrid PCR, FISH, and Southern blot in human cells

    PMID:8383590

    Open questions at the time
    • No functional data on PPP2CB activity or substrates at this stage
  2. 2006 High

    Demonstration that PPP2CA knockdown, but not PPP2CB knockdown, causes mitotic arrest established that the two catalytic isoforms are non-redundant in cell division, raising the question of what PPP2CB-specific roles exist.

    Evidence Isoform-specific siRNA and antisense in cultured cells with flow cytometry and live imaging

    PMID:17121919

    Open questions at the time
    • PPP2CB-specific substrates and mitotic functions undefined
    • No in vivo genetic confirmation of isoform non-redundancy
  3. 2011 High

    Conditional Ppp2cb knockout mice were phenotypically normal, confirming in vivo that PPP2CA can compensate for PPP2CB loss in organismal development and establishing genetic tools for tissue-specific studies.

    Evidence Cre-loxP conditional KO mouse with comprehensive phenotyping

    PMID:21998041

    Open questions at the time
    • No tissue-specific or stress-condition phenotypes explored
    • No double KO with PPP2CA to establish full essentiality
  4. 2012 High

    Identification of PPP2CB upregulation as the proximate cause of meiotic arrest in MARF1-deficient oocytes placed PPP2CB downstream of an RNA-binding protein in female meiotic control.

    Evidence Genetic epistasis in Marf1-mutant mouse oocytes with protein expression analysis

    PMID:22442484

    Open questions at the time
    • Direct PPP2CB substrates responsible for meiotic arrest unknown
    • Whether PPP2CA can substitute for PPP2CB in this context untested
  5. 2019 Medium

    Discovery that PPP2CB interacts with adenylyl cyclase 5 and that its knockdown reduces cAMP accumulation in striatal neurons revealed a role for PP2A-β in regulating neuronal cAMP signaling.

    Evidence BiFC interaction screen followed by genetic knockdown with cAMP assays in medium spiny neuron models

    PMID:31752385

    Open questions at the time
    • Specific phospho-site on AC5 dephosphorylated by PPP2CB unknown
    • Single-lab finding without independent replication
  6. 2019 High

    Structural and biochemical characterization of LB-100 as a catalytic-site inhibitor of PP2A (PPP2CA/PPP2CB) provided atomic-resolution understanding of the phosphatase active site, with metal-coordinating pharmacophore resolved at 1.65 Å.

    Evidence In vitro inhibition assays with purified enzymes plus X-ray co-crystal structure of the related PPP5C active site

    PMID:30679389

    Open questions at the time
    • Crystal structure was solved for PPP5C, not directly for PPP2CB; inference relies on active-site conservation
    • Selectivity between PPP2CA and PPP2CB not resolved
  7. 2022 High

    T cell-specific PPP2CB knockout showed the enzyme is dispensable for development but suppresses PI3K/Akt-dependent T cell activation, identifying a tissue-context in which PPP2CB has a non-redundant immunoregulatory function.

    Evidence Conditional KO (Lck-Cre), flow cytometry, PI3K inhibitor rescue, phospho-proteomics

    PMID:35068054

    Open questions at the time
    • Individual phospho-substrates in T cell activation not validated beyond proteomic candidates
    • In vivo immune consequence (infection, autoimmunity) not tested
  8. 2023 High

    Identification of G9a/EHMT2-pThr1045 as a direct PPP2CB substrate during late mitosis linked PPP2CB to re-establishment of repressive H3K9me2 chromatin after mitotic exit, providing the first specific mitotic substrate for this isoform.

    Evidence In vitro phosphatase assay, phosphomimic mutagenesis, ChIP-seq, co-IP, mass spectrometry, PPP2CB knockdown

    PMID:37661576

    Open questions at the time
    • Whether PPP2CA can also dephosphorylate G9a-pT1045 not formally excluded
    • Downstream gene expression consequences of impaired H3K9me2 restoration not mapped
  9. 2025 High

    REGγ-mediated proteasomal degradation of PPP2CB was shown to sustain TBK1 phosphorylation and IFN-β antiviral signaling, establishing PPP2CB as a negative regulator of innate immunity that is itself counter-regulated by a positive feedback loop.

    Evidence Co-IP, REGγ KO mice, viral infection survival, IFN-β assays, genetic rescue

    PMID:40736577

    Open questions at the time
    • Specific phospho-site on TBK1 dephosphorylated by PPP2CB not mapped
    • Contribution of PPP2CA to TBK1 regulation not assessed
  10. 2025 High

    PPP2CB was identified as the phosphatase that dephosphorylates LC3B, reducing its interaction with the mitophagy receptor OPTN and impairing PINK1/Parkin mitophagy — connecting the SCA12-associated regulatory subunit PPP2R2Bβ2 to neuronal toxicity through enhanced PPP2CB activity.

    Evidence Co-IP, proximity ligation assay, PPP2CB manipulation, mitophagy assays, pharmacological rescue, neuronal survival

    PMID:41059761

    Open questions at the time
    • Specific phospho-residue(s) on LC3B targeted by PPP2CB not identified
    • Whether SCA12 patient neurons show elevated PPP2CB-LC3B dephosphorylation in vivo not established
  11. 2025 High

    Transcriptional activation of PPP2CB by YAP1/TEAD1 in vascular smooth muscle cells established a signaling axis in which PPP2CB inhibits AMPK to relieve mTORC1 suppression and drive proliferation and neointima formation.

    Evidence TEAD1 ChIP, YAP1 overexpression/knockdown, AMPK phosphorylation, mTORC1 activity, PPP2CB rescue, VSMC proliferation assays

    PMID:41797917

    Open questions at the time
    • Whether PPP2CB directly dephosphorylates AMPK or acts through an intermediate not resolved
    • In vivo contribution versus PPP2CA in neointima model not dissected

Open questions

Synthesis pass · forward-looking unresolved questions
  • A systematic comparison of PPP2CB versus PPP2CA substrate specificity and holoenzyme assembly preferences remains lacking, leaving it unclear how cells achieve isoform-specific signaling despite near-identical catalytic domains.
  • No proteome-wide comparison of PPP2CB vs PPP2CA substrates
  • Structural basis for differential B-subunit association between isoforms unknown
  • Contribution of PPP2CB to human disease beyond expression correlations not genetically established

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0140096 catalytic activity, acting on a protein 5 GO:0016787 hydrolase activity 3
Localization
GO:0005829 cytosol 2 GO:0005634 nucleus 1
Pathway
R-HSA-162582 Signal Transduction 3 R-HSA-1640170 Cell Cycle 2 R-HSA-168256 Immune System 2 R-HSA-4839726 Chromatin organization 1 R-HSA-9612973 Autophagy 1
Complex memberships
PP2A holoenzyme

Evidence

Reading pass · 18 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
1993 PPP2CB (the β isoform of the PP2A catalytic subunit) was chromosomally mapped to human chromosome 8p12→p11.2 using somatic cell hybrids and fluorescence in situ hybridization, and a pseudogene (PPP2CBP) was identified on chromosome 16 by Southern blot analysis. Somatic cell hybrid PCR mapping, fluorescence in situ hybridization (FISH), Southern blot Cytogenetics and cell genetics High 8383590
1998 PP2A-β (PPP2CB) mRNA is intensely expressed in cerebellar floccular Purkinje cells and is upregulated within 2 days after unilateral labyrinthectomy in rats. Continuous infusion of the PP2A inhibitor okadaic acid into the flocculus prolonged UL-induced nystagmus, implicating PPP2CB upregulation in lesion-induced vestibular plasticity. In situ hybridization, Northern blot, differential display PCR, pharmacological inhibition (okadaic acid infusion) with behavioral readout Acta oto-laryngologica Medium 9840505
2006 Suppression of PP2Aα (PPP2CA), but not PP2Aβ (PPP2CB), by antisense oligonucleotides or siRNA was sufficient to induce metaphase arrest with lagging chromosomes and aberrant mitotic spindles, demonstrating that the two catalytic subunit isoforms have non-redundant roles in mitotic progression. siRNA knockdown, antisense oligonucleotides, flow cytometry, immunostaining, live cell time-lapse microscopy Molecular cancer therapeutics High 17121919
2008 PPP2CB transcript is significantly reduced in prostate carcinoma compared to benign prostate tissue, supporting its candidate role as a tumor suppressor on chromosome 8p, though no tumor-specific mutations were found in the coding exons. Quantitative RT-PCR across 45 prostate carcinomas and 13 benign tissues Cancer genomics & proteomics Low 18460741
2011 Conditional knockout of Ppp2cb (exon 3 deleted via Cre-loxP) in mice produces no obvious morphological or physiological defects, demonstrating that PPP2CB is dispensable for normal development when PPP2CA is present, and establishing a mouse genetic tool for spatiotemporal studies. Conditional knockout mouse generation (Cre-loxP), phenotypic analysis Genesis High 21998041
2012 Up-regulation of PPP2CB protein is identified as a key driver of the meiotic arrest phenotype in MARF1-deficient mouse oocytes; elevated PPP2CB levels correlate with failure to complete meiosis, placing PPP2CB downstream of MARF1 in the control of meiotic progression. Genetic mouse model (Marf1 mutation), protein expression analysis, epistasis Science High 22442484
2017 miR-1246 directly targets PPP2CB (and PRKAR1A) in mesenchymal stem/stromal cells, suppressing its expression and thereby promoting NF-κB-dependent transcription and release of pro-inflammatory mediators (IL-6, CCL2, CCL5), linking PPP2CB to regulation of inflammatory signaling in the tumor microenvironment. miRNA overexpression, luciferase reporter assay (direct targeting), Western blot, cytokine measurement Oncotarget Medium 28159925
2018 Co-immunoprecipitation demonstrated that PPP2CB (PP2A catalytic subunit β) directly interacts with GADD45α, and this interaction is associated with GADD45α-mediated promotion of AMPK activation and protection against acetaminophen-induced hepatotoxicity. Co-immunoprecipitation (LC-MS and Western blot confirmation), in vivo APAP injury model, GADD45α overexpression/knockout Cellular and molecular life sciences Medium 30151693
2019 PPP2CB was identified as a novel interactor of adenylyl cyclase type 5 (AC5) in striatal medium spiny neurons using bimolecular fluorescence complementation screening; PPP2CB knockdown reduced both acute and sensitized adenylyl cyclase activity, demonstrating that PP2A is an important persistent regulator of AC5/cAMP signaling in D1 and D2 MSNs. BiFC protein-protein interaction screen, genetic knockdown, cAMP accumulation assays in MSN cell lines and CAMPER mice Cells Medium 31752385
2019 PPP2CB was identified as a binding partner of JEV NS3 protein in a yeast two-hybrid screen of a human brain cDNA library, suggesting PPP2CB may be co-opted by Japanese encephalitis virus through its interaction with the viral NS3 helicase/protease. Yeast two-hybrid screen International journal of molecular sciences Low 31739611
2019 LB-100 was demonstrated to be a catalytic inhibitor of both PP2AC (PPP2CA/PPP2CB) and PPP5C in vitro using purified enzymes; the crystal structure of PPP5C co-crystallized with LB-100 (1.65 Å) revealed that the drug's 7-oxabicyclo[2.2.1]heptane-2,3-dicarbonyl moiety coordinates with active-site metal ions and conserved residues shared between PP2AC and PPP5C. In vitro phosphatase inhibition assays with purified enzymes, X-ray crystallography (1.65 Å), cell-based genetic disruption studies Molecular cancer therapeutics High 30679389
2022 T cell-specific knockout of PPP2CB (PPP2CBfl/fl Lck-Cre+) showed it is dispensable for T cell development and TCR-induced activation, but PPP2CB specifically suppresses PMA/ionomycin-induced T cell activation by negatively regulating the PI3K/Akt signaling pathway and Ca2+ flux; mass spectrometry-based phospho-peptide analysis identified potential substrates of PPP2CB during this activation. Conditional T cell-specific knockout mouse, flow cytometry (CD69, CD25, cytokines), PI3K inhibitor rescue, phospho-proteomics by MS The FEBS journal High 35068054
2023 PPP2CB dephosphorylates G9a/EHMT2 at Thr1045 (phosphorylated by Plk1 kinase during early mitosis) during late mitosis, thereby reactivating G9a catalytic activity and restoring H3K9me2 levels; this PPP2CB-mediated dephosphorylation is correlated with decreased H3S10 phosphorylation and is required for normal mitotic progression. In vitro kinase/phosphatase assays, site-directed mutagenesis (T1045E phosphomimic), ChIP-seq (chromatin accessibility), co-immunoprecipitation, mass spectrometry, PPP2CB knockdown Advanced science High 37661576
2023 Quantum-based ONIOM hybrid calculations on PP2A heterotrimers (containing PPP2CB/PPP2CA catalytic subunit) indicate that bidentate Arg89-substrate binding substantially lowers the activation barrier for phosphoserine hydrolysis (ΔH‡ ≈ +15.5 vs +18.8 kcal/mol), suggesting that Arg89 engagement with substrate phosphate—rather than with B-subunit Glu198—is critical for optimal PP2A catalytic function. Quantum mechanics/molecular mechanics (ONIOM UB3LYP/6-31G(d):UPM7) computational modeling of catalytic mechanism Frontiers in cell and developmental biology Low 37377738
2025 REGγ (a proteasome activator) directly interacts with PPP2CB and promotes its proteasomal degradation in macrophages during viral infection; this degradation prevents PPP2CB from dephosphorylating TBK1, thereby sustaining TBK1-IRF3 interaction and IFNβ-mediated antiviral signaling. IFNβ in turn upregulates REGγ, forming a positive feedback loop. Co-immunoprecipitation, REGγ knockout mice, viral infection models (in vivo mortality), Western blot, IFNβ production assays, genetic rescue Cellular and molecular life sciences High 40736577
2025 PPP2CB (PP2A-β) dephosphorylates LC3B, and this dephosphorylation reduces LC3B interaction with the mitophagy receptor OPTN, thereby impairing mitochondrial recruitment of phagophores during PINK1-PRKN-mediated mitophagy; overexpression of PPP2R2Bβ2 (the SCA12-associated isoform) enhances this PPP2CB-mediated LC3B dephosphorylation and causes neuronal toxicity. Co-immunoprecipitation, proximity ligation assay, PPP2CB genetic manipulation, mitophagy assays, pharmacological rescue (deferiprone), neuronal survival assays Autophagy High 41059761
2025 PPP2CB overexpression in hepatic cells exacerbates lipid accumulation and LDL-C uptake, while PPP2CB silencing mitigates these effects; co-immunoprecipitation and immunofluorescence co-localization confirmed a direct interaction between PPP2CB and LOX-1 (lectin-like oxidized LDL receptor-1), and PPP2CB-mediated lipid dysregulation operates through the LOX-1/MAPK/ERK signaling cascade in atherosclerosis. Overexpression and siRNA knockdown, co-immunoprecipitation, immunofluorescence co-localization, LDL-C uptake assay, Western blot, ApoE-/- mouse model Lipids in health and disease Medium 40611318
2026 YAP1 transcriptionally activates PPP2CB expression via the TEAD1 transcription factor in vascular smooth muscle cells (VSMCs); elevated PPP2CB inhibits AMPK (requiring upstream kinase CAMKK2), thereby relieving AMPK-mediated suppression of mTORC1 and driving VSMC proliferation and neointima formation. YAP1 siRNA knockdown and overexpression, TEAD1 ChIP, mTORC1 activity assays, AMPK phosphorylation, PPP2CB knockdown rescue, proliferation assays in human VSMCs iScience High 41797917

Source papers

Stage 0 corpus · 85 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2002 Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proceedings of the National Academy of Sciences of the United States of America 1479 12477932
2015 The BioPlex Network: A Systematic Exploration of the Human Interactome. Cell 1118 26186194
2017 Architecture of the human interactome defines protein communities and disease networks. Nature 1085 28514442
2015 A human interactome in three quantitative dimensions organized by stoichiometries and abundances. Cell 1015 26496610
2003 Complete sequencing and characterization of 21,243 full-length human cDNAs. Nature genetics 754 14702039
2007 Large-scale mapping of human protein-protein interactions by mass spectrometry. Molecular systems biology 733 17353931
2017 Roles of tau protein in health and disease. Acta neuropathologica 716 28386764
2021 Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 705 33961781
2011 Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Briefings in bioinformatics 656 21873635
2005 Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. The European journal of neuroscience 617 16262633
2011 Global landscape of HIV-human protein complexes. Nature 593 22190034
1990 Polyoma small and middle T antigens and SV40 small t antigen form stable complexes with protein phosphatase 2A. Cell 536 2153055
2006 Shugoshin collaborates with protein phosphatase 2A to protect cohesin. Nature 480 16541025
2004 The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome research 438 15489334
2022 OpenCell: Endogenous tagging for the cartography of human cellular organization. Science (New York, N.Y.) 432 35271311
2010 Systematic analysis of human protein complexes identifies chromosome segregation proteins. Science (New York, N.Y.) 421 20360068
2015 Panorama of ancient metazoan macromolecular complexes. Nature 407 26344197
1995 Protein kinase C is regulated in vivo by three functionally distinct phosphorylations. Current biology : CB 403 8749392
1995 Phosphatase activity toward abnormally phosphorylated tau: decrease in Alzheimer disease brain. Journal of neurochemistry 396 7616230
2006 Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. Nature 383 16541024
2004 14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. The Biochemical journal 372 14744259
2008 A PP2A phosphatase high density interaction network identifies a novel striatin-interacting phosphatase and kinase complex linked to the cerebral cavernous malformation 3 (CCM3) protein. Molecular & cellular proteomics : MCP 302 18782753
2003 WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer. The Journal of pathology 281 14517837
2012 A high-throughput approach for measuring temporal changes in the interactome. Nature methods 273 22863883
1992 p42 MAP kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1. Implications for Alzheimer's disease [corrected]. FEBS letters 269 1330687
2011 A directed protein interaction network for investigating intracellular signal transduction. Science signaling 258 21900206
2009 An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Molecular systems biology 223 19156129
2010 Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation. Nature cell biology 217 20562864
2016 A High-Density Map for Navigating the Human Polycomb Complexome. Cell reports 216 27705803
1999 Identification of a domain of Axin that binds to the serine/threonine protein phosphatase 2A and a self-binding domain. The Journal of biological chemistry 215 9920888
2016 An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. Nature communications 211 27173435
2012 MARF1 regulates essential oogenic processes in mice. Science (New York, N.Y.) 83 22442484
2018 Coding mutations in NUS1 contribute to Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 79 30348779
2017 miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by regulating PKA and PP2A. Oncotarget 63 28159925
2006 Expression analysis of imbalanced genes in prostate carcinoma using tissue microarrays. British journal of cancer 57 17146477
2013 MRNA and miRNA expression patterns associated to pathways linked to metal mixture health effects. Gene 55 24080485
2019 The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C. Molecular cancer therapeutics 47 30679389
2011 Generation of Ppp2Ca and Ppp2Cb conditional null alleles in mouse. Genesis (New York, N.Y. : 2000) 46 21998041
2006 Cantharidin-induced mitotic arrest is associated with the formation of aberrant mitotic spindles and lagging chromosomes resulting, in part, from the suppression of PP2Aalpha. Molecular cancer therapeutics 45 17121919
2019 Plasma-derived exosomal miR-183 associates with protein kinase activity and may serve as a novel predictive biomarker of myocardial ischemic injury. Experimental and therapeutic medicine 39 31258652
2019 Identification of Novel Adenylyl Cyclase 5 (AC5) Signaling Networks in D1 and D2 Medium Spiny Neurons using Bimolecular Fluorescence Complementation Screening. Cells 35 31752385
2008 Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer. Cancer genomics & proteomics 35 18460741
1996 Integrated map of the chromosome 8p12-p21 region, a region involved in human cancers and Werner syndrome. Genomics 35 8786118
1993 Localization of the genes encoding the catalytic subunits of protein phosphatase 2A to human chromosome bands 5q23-->q31 and 8p12-->p11.2, respectively. Cytogenetics and cell genetics 31 8383590
2022 Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association 30 35142023
2015 Ppp2ca knockout in mice spermatogenesis. Reproduction (Cambridge, England) 30 25628439
1997 Mutation analysis of 8p genes POLB and PPP2CB in bladder cancer. Cancer genetics and cytogenetics 27 9078303
2007 Isolation and characterization of okadaic acid binding proteins from the marine sponge Halichondria okadai. Biochemistry 21 17867706
2019 Hsp40 Protein DNAJB6 Interacts with Viral NS3 and Inhibits the Replication of the Japanese Encephalitis Virus. International journal of molecular sciences 20 31739611
2014 Resolving tumor heterogeneity: genes involved in chordoma cell development identified by low-template analysis of morphologically distinct cells. PloS one 20 24503940
2008 Differential expression of the catalytic subunits for PP-1 and PP-2A and the regulatory subunits for PP-2A in mouse eye. Molecular vision 19 18432318
2021 The role of phosphoprotein phosphatases catalytic subunit genes in pancreatic cancer. Bioscience reports 18 33270085
2012 Mass spectrometric analysis identifies a cortactin-RCC2/TD60 interaction in mitotic cells. Journal of proteomics 18 22282019
2009 Complex phosphatase regulation of Ca2+-activated Cl- currents in pulmonary arterial smooth muscle cells. The Journal of biological chemistry 16 19767392
2019 Novel Y Chromosome Retrocopies in Canids Revealed through a Genome-Wide Association Study for Sex. Genes 15 31027231
2022 Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration. Frontiers in immunology 13 35095855
2021 Wnt pathway-related three-mRNA clinical outcome signature in bladder urothelial carcinoma: computational biology and experimental analyses. Journal of translational medicine 13 34579753
2019 Proteomic Maps of Human Gastrointestinal Stromal Tumor Subgroups. Molecular & cellular proteomics : MCP 12 30804049
2018 GADD45α alleviates acetaminophen-induced hepatotoxicity by promoting AMPK activation. Cellular and molecular life sciences : CMLS 12 30151693
2008 Differential IL-4/Stat6 activities correlate with differential expression of regulatory genes SOCS-1, SHP-1, and PP2A in colon cancer cells. Journal of cancer research and clinical oncology 12 18536936
2016 Serine/threonine phosphatases and aquaporin-2 regulation in renal collecting duct. American journal of physiology. Renal physiology 11 27784696
2023 Secreted miR-210-3p, miR-183-5p and miR-96-5p reduce sensitivity to docetaxel in prostate cancer cells. Cell death discovery 10 38065937
2022 Protein phosphatase 2A catalytic subunit β suppresses PMA/ionomycin-induced T-cell activation by negatively regulating PI3K/Akt signaling. The FEBS journal 9 35068054
2021 The association of immunosurveillance and distant metastases in colorectal cancer. Journal of cancer research and clinical oncology 9 34476575
2023 Striatins and STRIPAK complex partners in clinical outcomes of patients with breast cancer and responses to drug treatment. Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 8 37691891
2023 Dynamic Phosphorylation of G9a Regulates its Repressive Activity on Chromatin Accessibility and Mitotic Progression. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 7 37661576
2019 Lineage-negative lymphoma with a helper innate lymphoid cell phenotype. Virchows Archiv : an international journal of pathology 7 31522287
1998 An implication of protein phosphatase 2A-beta in the rat flocculus for lesion-induced vestibular plasticity. Acta oto-laryngologica 7 9840505
2022 Characterization of a Read-through Fusion Transcript, BCL2L2-PABPN1, Involved in Porcine Adipogenesis. Genes 6 35327999
2019 A network-based variable selection approach for identification of modules and biomarker genes associated with end-stage kidney disease. Nephrology (Carlton, Vic.) 6 31464346
2025 Transcriptomic profiles of single-cell autophagy-related genes (ATGs) in lung diseases. Cell biology and toxicology 5 39920481
2020 The mRNA landscape profiling reveals potential biomarkers associated with acute kidney injury AKI after kidney transplantation. PeerJ 5 33312771
2025 Phillyrin for sepsis-related acute lung injury: A potential strategy suppressing GSK-3β. Molecular immunology 3 40359720
2025 PPP2CB aggravates atherosclerosis-related dyslipidemia via LOX-1/MAPK/ERK signaling pathway. Lipids in health and disease 2 40611318
2024 Proteomic analysis of plasma and duodenal tissue in celiac disease patients reveals potential noninvasive diagnostic biomarkers. Scientific reports 2 39622892
2023 Quantum-based modeling implies that bidentate Arg89-substrate binding enhances serine/threonine protein phosphatase-2A(PPP2R5D/PPP2R1A/PPP2CA)-mediated dephosphorylation. Frontiers in cell and developmental biology 2 37377738
2025 Adaptation of Diqing Tibetan pigs to hypoxic and cold environments through extramedullary hematopoiesis and uncoupled thermogenesis in the liver. BMC biology 1 40598433
2025 PPP2/PP2A-mediated dephosphorylation of LC3B links PINK1-PRKN/Parkin-mediated mitophagy to SCA12 pathogenesis. Autophagy 1 41059761
2024 Identification of reproduction-related genes in the hypothalamus of sheep (Ovis aries) using the nanopore full-length transcriptome sequencing technology. Scientific reports 1 39537852
1997 A 2.8 megabase YAC contig spanning D8S339, which is tightly linked to the Werner syndrome locus. Genome 1 9061915
2026 PP2A dysfunction mediated by PPP2R1A deficiency drives cGAS-STING-dependent hyperinflammation in SLE CD14+ monocytes. Clinical rheumatology 0 41582267
2026 Transcriptional control of PPP2CB by YAP1 and TEAD1 mediates AMPK inhibition and mTORC1 activation in vascular smooth muscle cells. iScience 0 41797917
2026 Glycolytic-Cholesterol Subtypes of Severe Asthma Reveal Distinct Immune-Inflammatory and Metabolic Phenotypes. Journal of inflammation research 0 41940036
2025 REGγ regulates antiviral response by activating TBK1-IFNβ signaling through degradation of PPP2CB. Cellular and molecular life sciences : CMLS 0 40736577
2023 [Circular RNA hsa_circ_0087893 participates in intraventricular hemorrhage occurrence and progression possibly as a competitive endogenous RNA in preterm infants]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University 0 37313816